Change in Director(s)

Ref: ADL/SE/2026-27/48 September 26, 2026 To, To, Listing/ Compliance Department Listing/ Compliance Department BSE Limited National Stock Exchange of India Limited, Phiroze Jeejeebhoy Towers, “Exchange Plaza”, Plot No. C/1, Dalal Street, G Block Bandra - Kurla Complex, Mumbai – 400 001 Bandra (East), Mumbai – 400051 BSE CODE: 524348 NSE SYMBOL: AARTIDRUGS Dear Sir/Madam, Sub: Change in Management Ref: Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 This is to inform you that the Shareholders of the Company at the 41st Annual General Meeting (“AGM”) held on Saturday, September 26, 2025, have inter-alia approved the following: 1. Shri Uday Moreshwar Patil (DIN: 01186406), Whole time Director of the Company, who was liable to retire by rotation at the 41st AGM and did not offer himself for re- appointment, accordingly ceased to be a Director at the conclusion of the 41st AGM held today i.e. September 26, 2026. 2. Appointment of Shri Nilesh Bhalchandra Patil (DIN: 08616943) as the Director with effect from conclusion of AGM, liable to retire by rotation, in place of Shri Uday Moreshwar Patil (DIN: 01186406), who retired by rotation in the AGM and had not offered himself for reappointment as a Director of the Company. 3. Appointment of Shri Nilesh Bhalchandra Patil (DIN: 08616943), as the Whole-time Director, liable to retire by rotation with effect from September 26, 2026. 4. Appointment of Shri Adhish Prakash Patil (DIN: 02629496), as the Director of the Company, with effect from October 01, 2026. 5. Appointment of Shri Adhish Prakash Patil (DIN: 02629496), as the Managing Director of the Company, with effect from October 01, 2026. 6. Re-appointment of Shri Harshit Manilal Savla (DIN: 00005340) as the Joint Managing Director of the Company for the period of five years with effect from June 01, 2027. 7. Re-appointment of Shri Harit Pragji Shah (DIN: 00005501) as the Whole-time Director of the Company for the period of five years with effect from June 01, 2027. 8. Re-appointment of Shri Hasmukh Bhavanji Dedhia (DIN: 07510925) as an Independent Director for the second term of five years with effect from March 29, 2027. 9. Re-appointment of Shri Sandeep Madhusudan Joshi (DIN: 00516409) as an Independent Director for the second term of five years with effect from March 29, 2027. 10. Re-appointment of Shri Ajit Eledath Venugopalan (DIN: 09439069) as an Independent Director for the second term of three years with effect from March 29, 2027. Pursuant to BSE circular with ref No. LIST/COMP/14/2018-19 and the NSE with ref No NSE/CM/2018/24 dated June 20, 2018 this is to confirm that None of the above mentioned persons are debarred from holding the office of a Director pursuant to any Order of SEBI or any other such authority. Independent Directors aforementioned are not related to the Promoters or Promoter Group. They fulfil the criteria of independence as required under the provisions of the Companies Act, 2013, the Rules framed thereunder and the SEBI (LODR) Regulations, 2015. The required details pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular SEBI/ HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026 are enclosed herewith in Annexure - A. Kindly take the same on record. Thanking you, Yours faithfully, FOR AARTI DRUGS LIMITED RUSHIKESH DEOLE COMPANY SECRETARY ICSI M. No.: F12932 Annexure A Disclosure of information pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Schedule III and SEBI Circular SEBI/ HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026: Sr. Particulars Shri Uday Moreshwar Patil Shri Nilesh Bhalchandra Patil Shri Adhish Prakash Patil No. (DIN: 01186406), (DIN: 08616943) (DIN: 02629496) 1. Reason for change Shri Uday Moreshwar Patil (DIN: Shri Nilesh B. Patil has been appointed as The current term of Shri Prakash M. Patil as viz. appointment, re- 01186406), Whole time Director Whole-time Director of the Company, the Managing Director is scheduled to expire appointment, of the Company, who was liable liable to retire by rotation, with effect from on May 31, 2027. In his communication to resignation, removal, to retire by rotation at the 41st the conclusion of the Annual General the Board, he expressed his desire to resign death or otherwise; AGM and did not offer himself Meeting dated September 26, 2026 for on ground of his intention to get early for re-appointment, accordingly period of 5 (five) years, in place of Shri retirement. This is in view of his belief that ceased to be a Director at the Uday M. Patil (DIN: 01186406), who it’s an appropriate time for an orderly conclusion of the 41st AGM held retired by rotation at the Annual General leadership transition. today i.e. September 26, 2026. Meeting and has not offered himself for re-appointment as a Director of the Shri Adhish P. Patil has been associated with Company. the Company as Chief Financial Officer since April 2014 and has played a pivotal role in the Company's growth and operational excellence over the years. During his tenure, he has been instrumental in leading the Company's finance, technical and commercial functions, demonstrating strong leadership and strategic vision. In recognition of his significant contributions and as a part of Company’s leadership transition, on the basis of the recommendation of Nomination and Remuneration Committee, the Board of Directors in its meeting held on July 31, 2026 has approved his appointment as the Managing Director with effect from October 1, 2026. The aforesaid recommendation of the Board has been approved by the members of the Company in the AGM dated September 26, 2026 2. date of September 26, 2026 Date of Appointment: September 26, Date of Appointment: October 1, 2026 appointment/re- 2026. appointment/cessation Terms of Appointment: As mentioned in the (as applicable) & term Terms of Appointment: As mentioned in Notice of 41st AGM of appointment/re- the Notice of 41st AGM appointment; 3. Brief Profile (in case NA Shri Nilesh Bhalchandra Patil holds a Shri Adhish P. Patil is a proven leader with of appointment); Bachelor of Commerce (B.Com.) degree 21 years of experience in Manufacturing and a Master of Business Administration Operations, Finance, Investor Relations, (MBA) in Human Resource Management. Regulatory Compliance, Consulting, Systems He has been associated with the Engineering and Information Technology for Company for over 33 years and is the Pharmaceutical and Consulting presently serving as General Manager – industries. He has a Bachelor of Engineering Administration. In his present role, he is (IT) degree from Mumbai University. He is a responsible for overseeing the Company’s gold medallist from the University of Florida’s warehouse operations, coordinating and Warrington College of Business liaising with various statutory and Administration with an MBA in Finance and regulatory authorities and managing Marketing. He has managed production general factory operations & efficiencies, projects, financial operations, administration. ERP implementation, automations for regulatory compliances for a publicly traded pharmaceutical Company. He also has experience in company operations and project management. 4. disclosure of NA None Shri Adhish P. Patil is the son of present relationships between Chairman and Managing Director of the directors (in case of Company, Shri Prakash M. Patil. appointment of a director). Sr. Particulars Shri Harshit Manilal Shri Harit Pragji Shah Shri Hasmukh Shri Ajit Eledath Shri Sandeep No. Savla (DIN: 00005501) Bhavanji Dedhia Venugopalan Madhusudan Joshi (DIN: 00005340) (DIN: 07510925) (DIN: 09439069 (DIN: 00516409) 1. Reason for change The existing terms of The existing terms of The existing terms of The existing terms of Shri The existing terms of viz. appointment, re- Shri Harshit M. Savla Shri Harit P. Sh [Showing first 8,000 characters — download PDF for full document]